Company filings profile · CIK 0001677077
Alzamend Neuro, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Alzamend Neuro, Inc. (ALZN): 13 filings in the last 90 days vs 9 in the prior 90 (filing-velocity rising ↑ · 1.44×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.
Material 8-K events — Alzamend Neuro, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Aug 3, 2026 | Entry into a Material Agreement; Delisting / Listing-Rule Failure; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jul 21, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Apr 17, 2026 | Item 5.07; Financial Statements and Exhibits | ↗ |
| Mar 20, 2026 | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Mar 6, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Nov 18, 2025 | Other Events; Financial Statements and Exhibits | ↗ |
| Oct 14, 2025 | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Oct 9, 2025 | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Sep 25, 2025 | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
Watch Alzamend Neuro, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Aug 4, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 3 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 4, 2026 | 5 | PRIMARY DOCUMENT | ↗ |
| Aug 3, 2026 | 8-K | Entry into a Material Agreement; Delisting / Listing-Rule Failure; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jul 22, 2026 | 10-K | ↗ | |
| Jul 21, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Apr 17, 2026 | 8-K | Item 5.07; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Mar 20, 2026 | 8-K | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | 10-Q | ↗ | |
| Mar 6, 2026 | 424B5 | ↗ | |
| Mar 6, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Feb 26, 2026 | DEFA14A | ↗ | |
| Feb 26, 2026 | DEF 14A | ↗ | |
| Feb 9, 2026 | PRE 14A | ↗ | |
| Dec 30, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Dec 23, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Dec 9, 2025 | 10-Q | ↗ | |
| Nov 18, 2025 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Oct 24, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Oct 14, 2025 | 8-K | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Oct 10, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Oct 9, 2025 | 8-K | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Oct 8, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Oct 7, 2025 | SCHEDULE 13D/A | ↗ | |
| Oct 3, 2025 | SCHEDULE 13D/A | ↗ | |
| Oct 3, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 30, 2025 | SCHEDULE 13D/A | ↗ | |
| Sep 30, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 25, 2025 | SCHEDULE 13D/A | ↗ | |
| Sep 25, 2025 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 25, 2025 | 8-K | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Sep 23, 2025 | SCHEDULE 13D/A | ↗ |